Board Of Regents, The University Of Texas System Patent Portfolio Statistics

Board Of Regents, The University Of Texas System

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Board Of Regents, The University Of Texas System look like?

Total Applications: 3,605
Granted Patents: 2,017
Grant Index 66.77 %
Abandoned/Rejected Applications: 1,004 (33.23%)
In-Process Applications: 570
Average Grant Time: 3.26 Years
Average Office Actions: 1.98

Which Technology Area Board Of Regents, The University Of Texas System is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
Opap Parked GAU 175
1642 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 147
1643 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 73
1644 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 72
1618 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs 62

How many patents are Board Of Regents, The University Of Texas System filing every year?

Year Total Applications
2022 0*
2021 123*
2020 195
2019 177
2018 189

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Board Of Regents, The University Of Texas System in USPTO?

Publication number:
Application number: 17/606,508

Abstract:
None

Publication date:
Applicant: Board Of Regents, The University Of Texas System
Inventors: Lovett Marissa


Publication number: US20220023484A1
Application number: 17/499,221

Abstract:
In one aspect, compositions and wound dressings are described herein. In some embodiments, a composition or wound dressing described herein comprises a mesh formed from a plurality of biodegradable polymer fibers; a first active agent dispersed in the biodegradable polymer fibers; a plurality of biodegradable polymer particles disposed in the mesh; and a second active agent dispersed in the biodegradable polymer particles. The particles can be disposed within the interiors of the fibers of the mesh or between the fibers of the mesh. In another aspect, a composition or wound dressing described herein comprises a first perforated mesh formed from a first plurality of biodegradable polymer fibers; and a second perforated mesh formed from a second plurality of biodegradable polymer fibers, wherein the second perforated mesh is disposed on the first perforated mesh in a stacked configuration and the first and second perforated meshes have different degrees of perforation.

Publication date: 2022-01-27
Applicant: Board Of Regents, The University Of Texas System
Inventors: Kytai Nguyen T


Publication number: US20220024978A1
Application number: 17/499,464

Abstract:
The present invention relates generally to a compound having both agonist activity at opioid receptor(s) and antagonist activity at NK1 receptor, and methods for producing and using the same. This combination of activities provides several synergistic and/or beneficial effects such as enhanced potency in analgesic effect and reduction or inhibition of tolerance.

Publication date: 2022-01-27
Applicant: Board Of Regents, The University Of Texas System
Inventors: Hruby J Victor


How are Board Of Regents, The University Of Texas System’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/606,508 Systems And Methods For An Ultrasound-Guided Percutaneous Nephrostomy Model
17/499,221 Wound Dressings And Applications Thereof OPAP Central, Docket
17/499,464 Peptides Comprising Opioid Receptor Agonist And Nk1 Receptor Antagonist Activities OPAP Central, Docket
17/602,975 Bifacial Spectrum Splitting Photovoltaic Module Sent to Classification contractor OPAP Central, Docket
17/498,740 Methods And Systems For Human Imperceptible Computerized Color Transfer 2644